BRAF and thyroid cancer: Based on our findings that all thyroid cancer cases (6.5%) occurred after the first melanoma diagnosis and due their common papillary pathological type (PTC), although our small patient cohort, we aimed to assess the rate of BRAF V600E mutation in this patient cohort.